GSK Director joins CPI as Director of Biologics

Brendan Fish, currently Director of New Product Introduction – Process Technology at GSK Barnard Castle, will join CPI in May 2022 where he will take up the position of Director of Biologics.

Dr Fish is a respected leader and expert with a multi-layered understanding of biopharma chemistry, manufacturing, and controls from discovery through to launch. He will support CPI with bringing together academia, industry, government to scale-up and commercialise novel biologics technologies to solve global healthcare challenges. This includes realising the agility of RNA technology as a platform – the technology that brought us COVID-19 vaccines that has immense potential for tackling other viruses – like flu, HIV, Zika – and in treating cancer.

At GSK, Brendan led the technical teams responsible for new product introduction and the scientific and technical aspects of medicines manufacture at Barnard Castle. At CPI in Darlington, Brendan will oversee the expansion of RNA capabilities at its National Biologics Manufacturing Centre, including new GMP facilities for the clinical manufacture of RNA and a training academy for RNA Therapeutics and Vaccines Manufacture.

At CPI, we use cutting-edge technology to collaborate with the pharma industry to develop, prove and commercialise new and improved manufacturing processes and biotherapeutics, allowing innovative medicines to reach the market faster. The team also shares its expertise in developing next-generation personalised drugs for specific diseases and patient groups, delivering significant advances in healthcare. We can synthesise, purify, manufacture, and encapsulate mRNA and saRNA using lipid nanoparticle technology and have achieved the largest scale RNA vaccine manufacture in the UK.

Brendan Fish said: 

I am very excited to be joining CPI at this crucial time in its growth of biologics and RNA vaccines. The work CPI does to support the development of medicines is incredible and inspiring, and I am looking forward to leveraging my experience to support CPI’s talented people and cutting-edge projects.”

Dave Tudor, Director of Medicines Manufacturing, Biologics and Quality at CPI, said: 

I am delighted to welcome Brendan as the new Director for Biologics. This is a growing and fast-paced area within the pharma sector and CPI are well-placed to provide significant value to patients and industry through advanced technology solutions. Brendan’s experience and leadership will play a significant role in CPI’s growth plans in this area.”

CPI is currently one of the few companies based in the UK capable of developing, manufacturing and encapsulating RNA vaccines ready for use in clinical trials in one location. The appointment of Brendan, alongside this end-to-end capability on one site, will help to drive the productivity and efficiency of the emerging RNA manufacturing industry in the UK.

News source: CPI.

Brendan Fish will join CPI as Director of Biologics in May 2022.

Other News

SiP Packaging Engineer

Radiation tech specialist to see half year revenues rise 45%

Kromek secures £5m bio-detection contract

Kromek seals $1.3m deal for ‘dirty bomb’ detectors with American customer

County Durham MedTech firm’s treatment could save the NHS over £180m per year

Science Park Manager – NETPark

Follow NETPark On Social Media

Keep up to date with the latest NETPark news and events.

NETPark Logo

The North East Technology Park provides a dynamic and supportive environment to accelerate the growth of ambitious, innovative, high tech companies into global markets. NETPark encourages collaborative multidisciplinary links, driving innovation, enterprise and economic prosperity.
We provide companies with access to a focused and international community where talent flourishes, ideas are generated and businesses have the support and resources to compete with the best in the world.

NETPark North East Technology Park

NETPark, North East Technology Park,
Sedgefield, County Durham TS21 3FD

Call Us: (+44) 01740 625250

The quality of the facilities at NETPark and the attitude of staff is first class. It has a really dynamic, innovative atmosphere.

Dr Neil Loxley, - Chief executive, IBEX

The proximity to the universities and the infrastructure are very important factors. Ultimately having a presence in Europe is very valuable to us and we intend to stay at NETPark for many years to come.

Dr Arnab Basu, - CEO, Kromek

CPI has developed a specialist offering to support SMEs looking to develop their printable electronics applications and our partnership with Business Durham has been instrumental in attracting several SMEs to locate here in the region.

Dr Jon Helliwell, - Director of Printable Electronics, CPI

It fits perfectly for us that we’re surrounded by like-minded companies at NETPark. There are a number of highly skilled people in the area who can help us grow our business. The facilities and services offered by NETPark are first class, they make office life simple and engaging.

Stuart Wilson, - CEO, Ascarii

We initially came because of the printable electronics centre but access to a highly skilled semi conductor workforce in the North East has been a key factor in us staying and growing here, as well as the value for money office space and the access to funding.

Ken Williamson, - COO, PragmatIC Printing

Access to quality facilities was one of the main drivers for deciding to locate the business at the NETPark. We have been able to use this as a launch pad to link into support from CPI and world-class expertise from Durham University.

Steve Clements, - Managing Director, aXenic
Go to Top